/ /

Lynda Charters
Imaging, 27-gauge systems capture retina surgeons’ focus
Retina surgeons considered 2015 to be an exciting time in the subspecialty in all areas and pointed to the availability and increased use of 27-gauge instrumentation as one of the real highlights of surgical retina.
Year brings advances in retinal imaging, screening, and gene/drug therapies
The topics of special interest to retina specialists during 2015 include optical coherence tomography angiography (OCTA) and screening for retinopathy of prematurity (ROP). Important research is taking place to determine the etiology of angiogenesis, possibly leading to targeting therapies in age-related macular degeneration (AMD), ROP, and diabetic retinopathy.
DRCR.net retinal treatment results take center stage in 2015
Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
Red light technology increases tear break-up time in dry eye patients
Treatment with red light technology resulted in a significant improvement in the tear break-up time in the vast majority of patients. This may be a future light treatment for the improvement of dry eye disease in patients with meibomian gland dysfunction.
Natural oral omega-3 supplement improves dry eye parameters in 3 months
The natural triglyceride form of omega-3 is an excellent treatment option for dry eye disease.
Topical integrin antagonist lifitegrast safely treats dry eye disease
Lifitegrast ophthalmic solution 5.0% (Shire Pharmaceuticals) administered twice daily for 1 year appeared safe and well-tolerated with no unexpected adverse events in a study.
Rethinking the EHR system: The most important components
Documenting practice flow and needs is a critical step in preparation for choosing or replacing an electronic health record system.
Anti-VEGF drugs: Safe and effective for treating DME
Data from large randomized trials indicate that diabetic macular edema can be treated safely and effectively with anti-vascular endothelial growth factor therapies.
Glaucoma drainage devices: Location, location, location
With glaucoma drainage devices gaining in popularity, the implantation technique must be tweaked to achieve the best results with the fewest complications.

Poll

View Results